Currently, we do not serve Alaska, Arkansas, Connecticut, Hawaii, Massachusetts, New Mexico and Missouri
Before 2012, there were few weight loss medications approved by the FDA
Nooms menu: compounded semaglutide Full-Dose ($279/month) and Microdose ($199/month), oral Metformin ($99/month), plus an entry-level oral GLP-1 announced December 2024 at $29 first month
Discussing this with biotech/pharma sponsors and building some dose escalation buffer into a protocol to keep the participant in the study and manage these AEs (when possible) can be a good strategy to keep participants in the trial & improve their experience
Dosing Safety: FDA has warned that dosing errors can occur with compounded injectable semaglutide when patients measure doses from multi-dose vials
How clinicians assess suitability before considering retatrutide When clinicians discuss emerging treatments such as retatrutide, the focus is not on comparison or speed of results, but on suitability